Cargando…
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis
Studies on serum alkaline phosphatase (ALP) and mortality risk in patients with end-stage renal disease (ESRD) undergoing dialysis have yielded conflicting results. This meta-analysis was designed to assess the association of serum ALP levels with cardiovascular or all-cause mortality risk among pat...
Autores principales: | Fan, Yu, Jin, Xin, Jiang, Menglin, Fang, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643374/ https://www.ncbi.nlm.nih.gov/pubmed/29038525 http://dx.doi.org/10.1038/s41598-017-13387-z |
Ejemplares similares
-
Associations of serum alkaline phosphatase level with all-cause and cardiovascular mortality in the general population
por: Yan, Wei, et al.
Publicado: (2023) -
Evaluation of the Relationship between the Serum Alkaline Phosphatase Level at Dialysis Initiation and All-Cause Mortality: A Multicenter, Prospective Study
por: Owaki, Akiko, et al.
Publicado: (2017) -
Age differences in associations of serum alkaline phosphatase and mortality among peritoneal dialysis patients
por: Wu, Juan, et al.
Publicado: (2019) -
Probable levetiracetam-related serum alkaline phosphatase elevation
por: Xiong, Nian, et al.
Publicado: (2012) -
Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients
por: Hwang, Seun Deuk, et al.
Publicado: (2016)